Rare diseases
Investigational molecules
Locations
Calle De Agustin De Betancourt 13 Entreplanta, 28003 Madrid, Spain
Fundacion Seimc Gesida focuses on clinical research in HIV care, with interest in maintaining virological suppression and evaluating treatment options for adults living with the infection. Its studies examine regimen selection and treatment continuation in people with stable control of HIV.
The sponsor’s work also includes comparisons of modern integrase inhibitor-based combinations used in long-term management of HIV.
Fundacion Seimc Gesida runs clinical trials in conditions such as HIV infection, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
Study Comparing DTG/3TC and BIC/FTC/TAF for Maintaining HIV Control in Adults
SpainStudy on Switching from Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide for HIV Patients with Good Control and Neuropsychiatric Concerns
SpainStudy on the Effectiveness of Rilpivirine-Based Treatment for HIV Patients with Metabolic Liver Disease Using Dolutegravir, Rilpivirine, and Emtricitabine/Tenofovir Combination
SpainIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
